Payment overview · 2025
General Payments
$166.67
2 reported records · 1 companies
Healthcare provider profile · identity verified
Susan Lee Hoffmann, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · JACKSONVILLE, FL · NPI 1760459788
Verified facts
What the public records show
CMS Open Payments records show Susan Lee Hoffmann, M.D. received $166.67 in general payments during 2025 across 2 reported records.
Insulet Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Insulet Corporation | Unresolved — no canonical attribution shown | $166.67 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $166.67 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OMNIPOD Normalized: omnipod |
Device | Insulet Corporation | $166.67 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 325 | 107 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 286 | 42 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 269 | 50 |
| Atorvastatin Calcium | Atorvastatin Calcium | 242 | 84 |
| Levothyroxine Sodium | Levothyroxine Sodium | 214 | 75 |
| Alprazolam | Alprazolam | 181 | 37 |
| Gabapentin | Gabapentin | 151 | 52 |
| Lisinopril | Lisinopril | 144 | 52 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 138 | 53 |
| Jardiance | Empagliflozin | 115 | 32 |
| Losartan Potassium | Losartan Potassium | 114 | 46 |
| Tramadol Hcl | Tramadol Hcl | 113 | 34 |
| Zolpidem Tartrate | Zolpidem Tartrate | 106 | 24 |
| Metformin Hcl | Metformin Hcl | 98 | 32 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 96 | 35 |
| Trazodone Hcl | Trazodone Hcl | 89 | 26 |
| Omeprazole | Omeprazole | 87 | 32 |
| Pantoprazole Sodium | Pantoprazole Sodium | 86 | 31 |
| Pregabalin | Pregabalin | 86 | 17 |
| Temazepam | Temazepam | 86 | 20 |
| Montelukast Sodium | Montelukast Sodium | 85 | 35 |
| Ozempic | Semaglutide | 84 | 20 |
| Clonazepam | Clonazepam | 83 | 16 |
| Lorazepam | Lorazepam | 78 | 17 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 76 | 22 |
| Metoprolol Succinate | Metoprolol Succinate | 71 | 28 |
| Escitalopram Oxalate | Escitalopram Oxalate | 70 | 22 |
| Hydrochlorothiazide | Hydrochlorothiazide | 69 | 24 |
| Furosemide | Furosemide | 68 | 29 |
| Nifedipine Er | Nifedipine | 61 | 20 |
| Eliquis | Apixaban | 60 | 17 |
| Carvedilol | Carvedilol | 53 | 20 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 53 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 51 | 17 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 51 | 19 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 50 | 15 |
| Oxycodone Hcl | Oxycodone Hcl | 49 | suppressed |
| Rybelsus | Semaglutide | 49 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 48 | 13 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 47 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 47 | 16 |
| Morphine Sulfate | Morphine Sulfate | 47 | suppressed |
| Meloxicam | Meloxicam | 46 | 18 |
| Atenolol | Atenolol | 45 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 45 | 17 |
| Tresiba Flextouch U-100 | Insulin Degludec | 42 | 13 |
| Azithromycin | Azithromycin | 41 | 39 |
| Mounjaro | Tirzepatide | 39 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 38 | 13 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 38 | 14 |
| Valsartan | Valsartan | 38 | 16 |
| Novolog Flexpen | Insulin Aspart | 36 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 36 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 35 | 14 |
| Metoprolol Tartrate | Metoprolol Tartrate | 35 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 35 | 13 |
| Tamsulosin Hcl | Tamsulosin Hcl | 33 | 16 |
| Clopidogrel | Clopidogrel Bisulfate | 32 | 11 |
| Humalog Kwikpen U-100 | Insulin Lispro | 31 | suppressed |
| Simvastatin | Simvastatin | 31 | 12 |
| Buspirone Hcl | Buspirone Hcl | 30 | 11 |
| Methylprednisolone | Methylprednisolone | 30 | 28 |
| Ropinirole Hcl | Ropinirole Hcl | 30 | suppressed |
| Famotidine | Famotidine | 29 | 12 |
| Sertraline Hcl | Sertraline Hcl | 29 | suppressed |
| Synthroid | Levothyroxine Sodium | 29 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 28 | 14 |
| Potassium Chloride | Potassium Chloride | 28 | 13 |
| Dexlansoprazole Dr | Dexlansoprazole | 27 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 26 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 26 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 26 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 26 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 26 | 11 |
| Allopurinol | Allopurinol | 25 | suppressed |
| Glimepiride | Glimepiride | 25 | 11 |
| Methocarbamol | Methocarbamol | 25 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 25 | suppressed |
| Estradiol | Estradiol | 24 | 12 |
| Ibandronate Sodium | Ibandronate Sodium | 24 | suppressed |
| Omnipod Dash Pods (Gen 4) | Insulin Pump Cart,cont Inf,bt | 24 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 23 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 23 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 23 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 23 | 20 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 21 |
| Ibuprofen | Ibuprofen | 21 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 21 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 20 | suppressed |
| Ezetimibe | Ezetimibe | 20 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 20 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 20 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 19 | suppressed |
| Diazepam | Diazepam | 19 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 19 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 18 | suppressed |
| Folic Acid | Folic Acid | 18 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 18 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 18 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 17 | 16 |
| Myrbetriq | Mirabegron | 17 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 17 | suppressed |
| Topiramate | Topiramate | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Celecoxib | Celecoxib | 16 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Linzess | Linaclotide | 16 | suppressed |
| Lovastatin | Lovastatin | 16 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 16 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 15 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 15 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 15 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Torsemide | Torsemide | 15 | suppressed |
| Cephalexin | Cephalexin | 14 | 12 |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Irbesartan | Irbesartan | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Testosterone | Testosterone | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Spironolactone | Spironolactone | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Finasteride | Finasteride | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Jantoven | Warfarin Sodium | 12 | suppressed |
| Januvia | Sitagliptin Phosphate | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | 11 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 11 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 11 | suppressed |
| Lyrica | Pregabalin | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Naproxen | Naproxen | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Prednisone | Prednisone | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 11 | suppressed |
| Xtampza Er | Oxycodone Myristate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $166.67 · 2 records | Insulet Corporation | OMNIPOD | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error